Blank Bio Announces $7.2M Seed Financing
Oversubscribed $7.2M seed; strategic PacBio collaboration for long-read tumor RNA-seq.
Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 5:44 PM
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
Blank Bio | RNA Intelligence for Precision Medicine Official site; notes YC backing.
Raised $7.2M across 1 funding round. Latest: $7.2M Seed (May 2026). Investors: Define Ventures, Leonis Capital, Nova Threshold, Ripple Ventures, SignalFire, Y Combinator. (High).
Seed (YC)
Verified facts
+1 more in Recent movement below
Funding
Raised $7.2M across 1 funding round. Latest: $7.2M Seed (May 2026). Investors: Define Ventures, Leonis Capital, Nova Threshold, Ripple Ventures, SignalFire, Y Combinator. (High).
Hiring
No hiring/careers evidence indexed (Low).
GitHub
No GitHub‑linked evidence indexed (Low).
Product / news
3 product/news‑styled row(s); headline risk without filings (High).
Traffic / social
No traffic/social evidence indexed (Low).
Oversubscribed $7.2M seed; strategic PacBio collaboration for long-read tumor RNA-seq.
YC S25 company profile.
No open roles indexed yet.
HTTP 404
TypeError: fetch failed
HTTP 404
HTTP 404
HTTP 404
HTTP 404
The score is an algorithmic estimate based on observed public company-level signals. It may be incomplete, stale, or inaccurate and is not investment, legal, tax, or business advice.
DealFlow score momentum
More runs will build history.
The score is an algorithmic estimate based on observed public company-level signals. It may be incomplete, stale, or inaccurate and is not investment, legal, tax, or business advice.
Latest momentum signal per category. Expand a card to inspect raw payloads.
Source types found
Strongest / recent news-style rows
Blank Bio Announces $7.2M Seed Financing
Wed, May 20, 05:44 PM · confidence 88%high quality
https://www.biospace.com/press-releases/blank-bio-announces-seed-financing-and-strategic-collaboration-with-pacbio-to-advance-rna-foundation-models-for-precision-oncologyBlank Bio | Y Combinator
Wed, May 20, 05:44 PM · confidence 85%high quality
https://www.ycombinator.com/companies/blank-bioLaunch YC: Blank Bio
Wed, May 20, 05:44 PM · confidence 85%medium quality
https://www.ycombinator.com/launches/O8Z-blank-bio-computational-toolkit-for-rna-therapeuticsNewest first · 5 event(s)
Oversubscribed $7.2M seed; strategic PacBio collaboration for long-read tumor RNA-seq.
Official site; notes YC backing.
YC S25 company profile.
Source: Blog / news
Blog | Blank Bio Home Blog Contact Blog Research updates and insights from the Blank Bio team Research mRNABench: a benchmarking suite for property prediction tasks We introduce a new benchmarking suite for mRNA property prediction tasks. It includes 10 curated datasets and 59 tasks spanning half-life prediction, translation efficiency, RBP binding, localization, and variant effect prediction. Ian Shi August 5, 2025…
YC launch on RNA therapeutics toolkit.
1 row(s)
Official site; notes YC backing.
https://www.blank.bio/1 row(s)
YC launch on RNA therapeutics toolkit.
https://www.ycombinator.com/launches/O8Z-blank-bio-computational-toolkit-for-rna-therapeutics2 row(s)
Oversubscribed $7.2M seed; strategic PacBio collaboration for long-read tumor RNA-seq.
https://www.biospace.com/press-releases/blank-bio-announces-seed-financing-and-strategic-collaboration-with-pacbio-to-advance-rna-foundation-models-for-precision-oncologyYC S25 company profile.
https://www.ycombinator.com/companies/blank-bio1 row(s)
Source name: Blog / news
Blog | Blank Bio Home Blog Contact Blog Research updates and insights from the Blank Bio team Research mRNABench: a benchmarking suite for property prediction tasks We introduce a new benchmarking suite for mRNA property prediction tasks. It includes 10 curated datasets and 59 tasks spanning half-life prediction, translation efficiency, RBP binding, localization, and variant effect prediction. Ian Shi August 5, 2025…
https://www.blank.bio/blogSign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.